Vanda Pharmaceuticals | VNDA - Market Capitalization


Vanda Pharmaceuticals reported $412M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
J&J USD 578.59B 562M Apr/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Veracyte USD 3.33B 627M Dec/2025